The largest database of trusted experimental protocols

3 protocols using pe anti mouse human cd44

1

Comprehensive Immunological Profiling of Tumor Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
4T1, H22, HepG2, NIH‐3T3, and Panc02 were purchased from BeNa Culture Collection, China. Anti‐mouse PD‐1 antibody (PD‐1 Ab, BE0146‐100 mg) was purchased from Bio X Cell. Anti‐human PD‐1 Ab was obtained as a gift from Livzon Pharmaceutical Group Inc., China. Flow cytometry antibodies included PE anti‐mouse CD274 (B7‐H1, PD‐L1) (124308), APC/Cyanine7 anti‐mouse CD45 (103132), FITC anti‐mouse CD3 (100204), Brilliant Violet 421 anti‐mouse CD4 (100563), PE/Cy7 anti‐mouse CD8a (100722), PE anti‐mouse IFN‐γ (505808), Alexa Fluor 647 anti‐human/mouse Granzyme B (515406), APC anti‐mouse Ki‐67 (652406), PE anti‐mouse/human CD44 (103008), PE anti‐mouse Ly‐6G/Ly‐6C (Gr‐1) (108407), APC/Cyanine7 anti‐mouse/human CD11b (101226), Brilliant Violet 421 anti‐mouse F4/80 (123137), PE anti‐mouse CD86 (105008), PE/Cy7 anti‐mouse CD206 (MMR) (141720), Alexa Fluor 647 anti‐mouse FOXP3 (126408), APC anti‐mouse CD49b (pan‐NK cells) (108910), PE anti‐mouse CD25 (102008), PE anti‐mouse/human CD44 (103008), APC anti‐mouse CD62L (104412), Zombie Aqua Fixable Viability Kit (423102), Cell Activation Cocktail (with Brefeldin A) (423304), True‐Nuclear Transcription Factor Buffer Set (424401), and Intracellular Staining Permeabilization Wash Buffer (10X) (421002) were purchased from BioLegend.
+ Open protocol
+ Expand
2

Characterization of Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SMCs and PBMCs were incubated with FcR Blocking Reagent (Miltenyi Biotec, 130-092-575) at 4 °C for 10 min to block non-specific immunoglobulin binding to Fc receptors, stained with Viobility 405/520 Fixable Dye (Miltenyi Biotec, 130-092-575) at 4 °C for 30 min, and washed once with FACS buffer. The cells were incubated with specific antibodies or isotype controls, according to the manufacturer’s guidelines. The antibodies used were as follows: anti-mouse Abs against CD3ε-APC-Vio770, mouse (Miltenyi Biotec, 130-117-676), CD8a-PE-Vio770, mouse (Miltenyi Biotec, 130-102-358), PE/Dazzle™ 594 anti-mouse CD4 Antibody (BioLegend, 100456), Brilliant Violet 421™ anti-mouse TIGIT (Vstm3) Antibody (BioLegend, 142111), Brilliant Violet 421™ Mouse IgG1, κ Isotype Ctrl Antibody (BioLegend, 400157), FITC anti-mouse CD226 (DNAM-1) (BioLegend, 128803), FITC Rat IgG2b, κ Isotype Ctrl Antibody (BioLegend, 400634), PE anti-mouse/human CD44 (BioLegend, 103007), and Alexa Fluor® 488 anti-mouse CD62L Antibody (BioLegend, 104420). All flow cytometry acquisitions were performed using CytoFLEX (Beckman Coulter, Brea, CA, USA) under the same application settings. Flow cytometry data analysis was performed using CytExpert 2.1 software.
+ Open protocol
+ Expand
3

Isolation and Characterization of Mouse BMSCs and BMDMs

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMSCs were isolated using a previously reported method [14 (link)]. In brief, the mouse femur was obtained, and the marrow cavity was washed with culture medium. The washing fluid was centrifuged and resuspended, and cells were inoculated into the culture dish. BMSCs were identified by flow cytometry, and antibodies used for flow cytometry were: PE anti-mouse/human CD44 (BioLegend, 103007, 1: 20), APC anti-mouse stem cell antigen 1 (Sca-1; BioLegend, 108111, 1: 80), PerCP/Cyanine5.5 anti-mouse CD34 (BioLegend, 128608, 1: 20), and PE/Cyanine7 anti-mouse CD45 (BioLegend, 103114, 1: 80). All experiments involved cells at passages 3–5.
Bone marrow-derived macrophages (BMDMs) were isolated and treated according to a previous method [15 ]. Typically, BMDMs were isolated using the same method of BMSCs isolation. The cell number was determined after resuspension, and the cell concentration was adjusted to 0.5×106/ml. Then, 20 ng/ml macrophage colony stimulating factor (M-CSF; PeproTech, 315-02-10, America) was added to the culture medium. The nonadherent cells were removed after 3 days, and fresh M-CSF-containing culture medium was added. Four days later, the mature macrophages were harvested for subsequent experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!